-
1
المؤلفون: Pascal Wolter, Brigitte Decallonne, Vincent Verschaeve, Philip R. Debruyne, Julie Bastin, Diether Lambrechts, Jean-Pascal Machiels, Thomas Van Brussel, Evelyne Lerut, Vincent Richard, Annelies Verbiest, Oliver Bechter, Patrick Schöffski, Benoit Beuselinck, Emilie Werbrouck
المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Centre du cancer
المصدر: Acta clinica Belgica, Vol. 74, no. 3, p. 180-188 (2019)
مصطلحات موضوعية: Adult, Male, renal cell carcinoma, endocrine system, endocrine system diseases, Abcg2, thyroid dysfunction, efflux pumps, sunitinib, Vascular Endothelial Growth Factor Receptor, Antineoplastic Agents, urologic and male genital diseases, Polymorphism, Single Nucleotide, 03 medical and health sciences, 0302 clinical medicine, Hypothyroidism, Thyroid dysfunction, Renal cell carcinoma, Sunitinib, medicine, ATP Binding Cassette Transporter, Subfamily G, Member 2, Humans, 030212 general & internal medicine, Adverse effect, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Aged, Aged, 80 and over, biology, business.industry, General Medicine, Middle Aged, medicine.disease, Kidney Neoplasms, Neoplasm Proteins, respiratory tract diseases, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Female, Efflux, polymorphisms, business, Tyrosine kinase, medicine.drug
وصف الملف: Print-Electronic
-
2
المؤلفون: Evelyne Lerut, Vincent Verschaeve, Diether Lambrechts, A. Mejean, Thomas Van Brussel, Gabrielle Couchy, Stéphane Oudard, Patrick Schöffski, Jessica Zucman-Rossi, Vincent Richard, Herlinde Dumez, Annelies Verbiest, Maxime Vanmechelen, Benoit Beuselinck, Pascal Wolter, Jean-Pascal Machiels, Maarten Albersen, Philip R. Debruyne
المساهمون: Leuven Center for Cancer Biology (VIB-KU-CCB), Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven)-Vlaams Instituut voor Biotechnologie [Ghent, Belgique] (VIB), Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Génomique Fonctionnelle des Tumeurs Solides (U1162), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of General Medical Oncology [Leuven], University Hospitals Leuven [Leuven], Anglia Ruskin University (ARU), CHU Ambroise Paré [Mons, Belgium], Grand Hôpital de Charleroi [Belgium], Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), St. Nikolaus-Hospital Eupen [Eupen, Belgium], UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Unité d'oncologie médicale, CCSD, Accord Elsevier
المصدر: Clinical Genitourinary Cancer
Clinical Genitourinary Cancer, Elsevier, 2019, 17 (2), pp.e235-e246. ⟨10.1016/j.clgc.2018.11.002⟩
Clinical genitourinary cancer, Vol. 17, no. 2, p. e235-e246 (2019)
Clinical genitourinary cancer, Vol. 17, no.2, p. e235-e246 (2019)مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Genotype, Urology, 030232 urology & nephrology, Angiogenesis inhibitor, Polymorphism, Single Nucleotide, Disease-Free Survival, Pazopanib, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, medicine, Sunitinib, Humans, Progression-free survival, Neoplasm Metastasis, Receptor, Fibroblast Growth Factor, Type 2, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Germ-Line Mutation, Aged, Retrospective Studies, Outcome, Aged, 80 and over, Fibroblast growth factor receptor 2, business.industry, Hazard ratio, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, Biomarker, Single nucleotide polymorphisms, Middle Aged, medicine.disease, Prognosis, Kidney Neoplasms, [SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, 3. Good health, Clear cell renal cell carcinoma, Treatment Outcome, 030220 oncology & carcinogenesis, Female, business, medicine.drug
وصف الملف: application/pdf; Print-Electronic
-
3
المؤلفون: Anne Sacré, Patrick Schöffski, Philip R. Debruyne, Clement Korenbaum, Tine Loyson, Herlinde Dumez, Benoit Beuselinck, Evelyne Lerut, Philippe Barthélémy, Steven Joniau, Pascal Wolter, Mickael Burgy, Raymond Oyen
المصدر: Acta Oncologica. 55:329-340
مصطلحات موضوعية: Adult, Male, Vascular Endothelial Growth Factor A, medicine.medical_treatment, Salvage therapy, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Humans, Medicine, Radiology, Nuclear Medicine and imaging, Molecular Targeted Therapy, 030212 general & internal medicine, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Survival rate, Aged, Neoplasm Staging, Retrospective Studies, Salvage Therapy, business.industry, Hematology, General Medicine, Middle Aged, Prognosis, medicine.disease, Kidney Neoplasms, Survival Rate, Vascular endothelial growth factor A, Clear cell renal cell carcinoma, Oncology, 030220 oncology & carcinogenesis, Disease Progression, Cancer research, Female, Neoplasm Recurrence, Local, business, Tyrosine kinase, Progressive disease, Follow-Up Studies
وصف الملف: Print-Electronic; application/pdf
-
4
المؤلفون: Reinhard Dummer, Bijoyesh Mookerjee, Mayur M. Amonkar, Andrzej Mackiewicz, Diane Opatt McDowell, Peng Sun, Jean-Jacques Grob, Keith T. Flaherty, Antoni Ribas, Evgeny Levchenko, Florent Grange, Paul Nathan, Piotr Rutkowski, Mikhail Lichinitser, Axel Hauschild, Georgina V. Long, Dirk Schadendorf, Jeffrey J. Legos, Vanna Chiarion-Sileni, Pascal Wolter, Kamil Drucis, Caroline Robert, Daniil Stroyakovskiy, Boguslawa Karaszewska, Jacob Schachter
المساهمون: University of Zurich, Grob, Jean Jacques
المصدر: The Lancet Oncology. 16:1389-1398
مصطلحات موضوعية: Oncology, Indoles, Skin Neoplasms, Time Factors, DNA Mutational Analysis, Medizin, Administration, Oral, law.invention, Randomized controlled trial, Risk Factors, law, Surveys and Questionnaires, Antineoplastic Combined Chemotherapy Protocols, Oximes, Clinical endpoint, Prospective Studies, Vemurafenib, Melanoma, Trametinib, Sulfonamides, education.field_of_study, Imidazoles, 10177 Dermatology Clinic, MAP Kinase Kinase Kinases, Intention to Treat Analysis, Phenotype, Treatment Outcome, Disease Progression, 2730 Oncology, medicine.drug, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Combination therapy, Pyridones, Population, 610 Medicine & health, Pyrimidinones, Disease-Free Survival, Drug Administration Schedule, Internal medicine, Biomarkers, Tumor, medicine, Humans, Genetic Predisposition to Disease, education, Protein Kinase Inhibitors, business.industry, Dabrafenib, medicine.disease, Surgery, Mutation, Quality of Life, business
وصف الملف: 634_Grob JJ_Comparison of dabrafenib and trametinib combination therapy with vemurafenib_Lancet Oncology 2015.pdf - application/pdf
-
5
المؤلفون: Julie Bastin, Annelies Verbiest, Maarten Albersen, Hans Wildiers, Brigitte Decallonne, Patrick Schöffski, Kevin Punie, Paul Clement, Oliver Bechter, Benoit Beuselinck, Emilie Werbrouck, Raymond Oyen, Evelyne Lerut, Herlinde Dumez, Dirk Vanderschueren, Pascal Wolter, F. J. S. H. Woei-A-Jin
المصدر: Acta clinica Belgica. 74(3)
مصطلحات موضوعية: Oncology, Adult, Male, Vascular Endothelial Growth Factor A, medicine.medical_specialty, Indazoles, medicine.medical_treatment, Antineoplastic Agents, urologic and male genital diseases, Prospective evaluation, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, medicine, Prevalence, Sunitinib, Humans, Testosterone, 030212 general & internal medicine, Molecular Targeted Therapy, Prospective Studies, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Aged, Aged, 80 and over, Sirolimus, Sulfonamides, business.industry, Hypogonadism, General Medicine, Luteinizing Hormone, Middle Aged, medicine.disease, Kidney Neoplasms, Cross-Sectional Studies, Pyrimidines, Male patient, 030220 oncology & carcinogenesis, business
-
6
المؤلفون: Patrick Schöffski, Michiel Strijbos, Evelyne Lerut, Pascal Wolter, Liesbeth De Wever, Johannes Berkers, Raymond Oyen, Herlinde Dumez, Robert Paridaens, Steven Joniau, Hendrik Van Poppel, Benoit Beuselinck
المصدر: Clinical Genitourinary Cancer. 12:e205-e214
مصطلحات موضوعية: Male, Niacinamide, medicine.medical_specialty, Pathology, Indazoles, Indoles, Axitinib, Urology, medicine.medical_treatment, Angiogenesis Inhibitors, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Kidney, Nephrectomy, Gastroenterology, Disease-Free Survival, Targeted therapy, Internal medicine, Sunitinib, medicine, Humans, Pyrroles, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Retrospective Studies, Sulfonamides, business.industry, Phenylurea Compounds, Hazard ratio, Imidazoles, Cell Differentiation, Middle Aged, Sorafenib, medicine.disease, Primary tumor, Kidney Neoplasms, Bevacizumab, Clear cell renal cell carcinoma, Pyrimidines, Receptors, Vascular Endothelial Growth Factor, Treatment Outcome, Oncology, Female, Metastasectomy, business, Tyrosine kinase, Clear cell
-
7
المؤلفون: Patrick Schöffski, Holger Fritsch, Patricia Glomb, Ahmad Awada, Pascal Wolter, Gerd Munzert, Herlinde Dumez, S. Bartholomeus, M. Taton, Thierry Gil
المصدر: European Journal of Cancer. 48:179-186
مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Antineoplastic Agents, Neutropenia, Pharmacology, Cohort Studies, Young Adult, chemistry.chemical_compound, Pharmacokinetics, Neoplasms, Internal medicine, Humans, Medicine, Adverse effect, Protein Kinase Inhibitors, Aged, Volume of distribution, Dose-Response Relationship, Drug, business.industry, Pteridines, Volasertib, Middle Aged, medicine.disease, Clinical trial, chemistry, Tolerability, Female, business, Febrile neutropenia, Half-Life
-
8
المؤلفون: A. de Reyniès, Gwenaelle Gravis, Patrick Schöffski, Evelyne Lerut, Christine Theodore, Johnny Jean-Baptiste, Sylvie Job, Steven Joniau, J.J. Patard, Laurence Albiges, Virginie Verkarre, A. Mejean, Pascal Wolter, R. Elaidi, Gabrielle Couchy, Benoit Rousseau, Jessica Zucman-Rossi, Benoit Beuselinck, Stéphane Oudard
المصدر: British Journal of Cancer
مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, Bone Neoplasms, Proto-Oncogene Mas, RANK/RANKL/OPG pathway, Disease-Free Survival, Metastasis, Osteoprotegerin, bone metastases, Renal cell carcinoma, Internal medicine, Carcinoma, Medicine, Humans, Lung cancer, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Receptor Activator of Nuclear Factor-kappa B, business.industry, RANK Ligand, Bone metastasis, Middle Aged, Protein-Tyrosine Kinases, medicine.disease, Prognosis, Kidney Neoplasms, anti-VEGFR-TKIs, Clear cell renal cell carcinoma, Genes, src, Endocrinology, Receptors, Vascular Endothelial Growth Factor, outcome, Intercellular Signaling Peptides and Proteins, Female, business, Liver cancer, Translational Therapeutics, Signal Transduction
وصف الملف: Print-Electronic; application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27ed1e14d13660d170b144ad92285cce
https://lirias.kuleuven.be/handle/123456789/515734 -
9
المؤلفون: Pascal Wolter, Dirk Schadendorf, Daniil Stroiakovski, Michael Lichinitser, Jeff Legos, Paul Nathan, Peng Sun, Kamil Drucis, Keith T. Flaherty, Boguslawa Karaszewska, Antoni Ribas, Florent Grange, Anne-Marie Martin, Shonda M Little, Reinhard Dummer, Ivana Krajsová, Laurent Mortier, Vanna Chiarion-Sileni, Wendy A. Crist, Paul Lorigan, Stephen D. Rubin, Andrzej Mackiewicz, Piotr Rutkowski, Jacob Schachter, Caroline Robert, Georgina V. Long, Axel Hauschild
المساهمون: University of Zurich, Robert, Caroline
مصطلحات موضوعية: Oncology, Male, Keratoacanthoma, Indoles, Skin Neoplasms, Medizin, Kaplan-Meier Estimate, 2700 General Medicine, chemistry.chemical_compound, Antineoplastic Combined Chemotherapy Protocols, Oximes, Vemurafenib, Melanoma, Trametinib, Aged, 80 and over, education.field_of_study, Sulfonamides, Hazard ratio, Imidazoles, 10177 Dermatology Clinic, General Medicine, Middle Aged, Intention to Treat Analysis, Female, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Adolescent, Pyridones, Population, 610 Medicine & health, Pyrimidinones, Young Adult, Internal medicine, medicine, Humans, education, neoplasms, Protein Kinase Inhibitors, Aged, Cobimetinib, Mitogen-Activated Protein Kinase Kinases, business.industry, Dabrafenib, medicine.disease, Survival Analysis, Surgery, chemistry, Mutation, business
وصف الملف: Robert C et al. - N Engl J Med 2014.pdf - application/pdf; Print-Electronic; application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb174f02e29f4375b8bd8c23ddb74764
https://doi.org/10.5167/uzh-107163 -
10
المؤلفون: Reinhard Dummer, Piotr Rutkowski, Pascal Wolter, Mayur M. Amonkar, Michelle Casey, Lev V. Demidov, Ann Rutten, Frank S. Wu, Dirk Schadendorf, Peter Mohr, Laurie Sherman, Mohammed M. Milhem, Claus Garbe, Kiran Patel, Jessica C. Hassel, C Lefeuvre-Plesse, Uwe Trefzer, Gustav J. Ullenhag, Kelly M. Grotzinger, Neil Steven, Caroline Robert
المساهمون: University of Zurich, Schadendorf, D
مصطلحات موضوعية: Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Paclitaxel, Exacerbation, Pyridones, Nausea, Health Status, Dacarbazine, Population, 2720 Hematology, Medizin, Antineoplastic Agents, 610 Medicine & health, Pyrimidinones, Disease-Free Survival, Quality of life, Surveys and Questionnaires, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Progression-free survival, education, Melanoma, Protein Kinase Inhibitors, neoplasms, Trametinib, education.field_of_study, business.industry, 10177 Dermatology Clinic, Original Articles, Hematology, Middle Aged, MAP Kinase Kinase Kinases, Chemotherapy regimen, Surgery, Oncology, Mutation, Quality of Life, 2730 Oncology, medicine.symptom, business, medicine.drug
وصف الملف: 572_Schadendorf_D_et_al._-_Ann_Oncol_2014.pdf - application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f778db8271f726ba0f473e3aa46d690d
https://www.zora.uzh.ch/id/eprint/93240/
إعادة تعيين المنقحات
عرض المنقحات (%%عد%%)
PDF full text from Publisher 
Full Text via ClinicalKey